Looks similar to OPY at this stage.
Thundering negative operating cash flow with minimal revenue, minimal growth, low bank balance and low market capitalisation.
Heading towards the downard spiral as share price craters.
How does it turn this around?
- Forums
- ASX - By Stock
- QFE
- Ann: Investor presentation - H1 FY22 results
Ann: Investor presentation - H1 FY22 results, page-4
Featured News
Add QFE (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $38.72M |
Open | High | Low | Value | Volume |
11.5¢ | 12.0¢ | 11.5¢ | $870 | 7.458K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 81025 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 6550 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 81025 | 0.110 |
3 | 52500 | 0.105 |
2 | 110000 | 0.100 |
1 | 5051 | 0.099 |
1 | 10000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 6550 | 1 |
0.120 | 141500 | 3 |
0.130 | 172340 | 3 |
0.135 | 1097 | 1 |
0.140 | 315849 | 6 |
Last trade - 15.54pm 15/11/2024 (20 minute delay) ? |
Featured News
QFE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online